Literature DB >> 11368376

Prognostic factors in acute myelogenous leukemia.

E H Estey1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11368376     DOI: 10.1038/sj.leu.2402057

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  6 in total

1.  Prognostic factors for intensive care unit admission, intensive care outcome, and post-intensive care survival in patients with de novo acute myeloid leukemia: a single center experience.

Authors:  Peter Schellongowski; Thomas Staudinger; Michael Kundi; Klaus Laczika; Gottfried J Locker; Andja Bojic; Oliver Robak; Valentin Fuhrmann; Ulrich Jäger; Peter Valent; Wolfgang R Sperr
Journal:  Haematologica       Date:  2010-11-11       Impact factor: 9.941

2.  Association between RAD51 gene polymorphism (-135G/C) and susceptibility of myelodysplastic syndrome and acute leukemia: evidence based on a meta-analysis.

Authors:  Ya-zhou He; Xin Hu; Xiao-sa Chi; Yuan-chuan Zhang; Xiang-Bing Deng; Ming-tian Wei; Zi-qiang Wang; Yan-hong Zhou
Journal:  Tumour Biol       Date:  2013-08-17

3.  Herbo-mineral ayurvedic treatment in a high risk acute promyelocytic leukemia patient with second relapse: 12 years follow up.

Authors:  Balendu Prakash; Purvish M Parikh; Sanjoy K Pal
Journal:  J Ayurveda Integr Med       Date:  2010-07

4.  Association of MDR1 G2677T polymorphism and leukemia risk: evidence from a meta-analysis.

Authors:  Yulan Yan; Hongjie Liang; Li Xie; Yu He; Meng Li; Ruolin Li; Shan Li; Xue Qin
Journal:  Tumour Biol       Date:  2013-10-20

5.  Association between TP53 Arg72Pro polymorphism and leukemia risk: a meta-analysis of 14 case-control studies.

Authors:  Xin Tian; Shundong Dai; Jing Sun; Shenyi Jiang; Youhong Jiang
Journal:  Sci Rep       Date:  2016-04-07       Impact factor: 4.379

6.  Microarray-based analysis and clinical validation identify ubiquitin-conjugating enzyme E2E1 (UBE2E1) as a prognostic factor in acute myeloid leukemia.

Authors:  Hongmei Luo; Yu Qin; Frederic Reu; Sujuan Ye; Yang Dai; Jingcao Huang; Fangfang Wang; Dan Zhang; Ling Pan; Huanling Zhu; Yu Wu; Ting Niu; Zhijian Xiao; Yuhuan Zheng; Ting Liu
Journal:  J Hematol Oncol       Date:  2016-11-17       Impact factor: 17.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.